A detailed history of Texas Bank & Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Texas Bank & Trust CO holds 9,075 shares of BMY stock, worth $424,800. This represents 0.15% of its overall portfolio holdings.

Number of Shares
9,075
Previous 9,380 3.25%
Holding current value
$424,800
Previous $434 Million 5.74%
% of portfolio
0.15%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

SELL
$43.31 - $48.98 $13,209 - $14,938
-305 Reduced 3.25%
9,075 $409 Million
Q2 2025

Aug 05, 2025

SELL
$44.12 - $59.6 $5,382 - $7,271
-122 Reduced 1.28%
9,380 $434 Million
Q1 2025

May 15, 2025

SELL
$53.9 - $63.11 $200,130 - $234,327
-3,713 Reduced 28.1%
9,502 $580 Million
Q4 2024

Feb 14, 2025

BUY
$51.92 - $59.94 $686,122 - $792,107
13,215 New
13,215 $747 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Texas Bank & Trust CO Portfolio

Follow Texas Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Texas Bank & Trust CO with notifications on news.